Skip to main content
Midas Edge

TENET HEALTHCARE CORP

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

THC$289.00+2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TENET HEALTHCARE CORPORATION(Registrant)
Date: February 16, 2024By:/s/ R. SCOTT RAMSEY
R. Scott RamseySenior Vice President, Controller (Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Date: February 16, 2024By:/s/ SAUMYA SUTARIA
Saumya Sutaria, M.D.Chairman of the Board and Chief Executive Officer(Principal Executive Officer)
Date: February 16, 2024By:/s/ SUN PARK
Sun ParkExecutive Vice President and Chief Financial Officer(Principal Financial Officer)
Date: February 16, 2024By:/s/ R. SCOTT RAMSEY
R. Scott RamseySenior Vice President, Controller(Principal Accounting Officer)
Date: February 16, 2024By:/s/ VINEETA AGARWALA
Vineeta Agarwala, M.D., PhDDirector
Date: February 16, 2024By:/s/ JAMES L. BIERMAN
James L. BiermanDirector
Date: February 16, 2024By:/s/ ROY D. BLUNT
Roy D. BluntDirector
Date: February 16, 2024By:/s/ RICHARD FISHER
Richard FisherDirector
Date: February 16, 2024By:/s/ MEGHAN M. FITZGERALD
Meghan M. FitzGerald, DrPHDirector
Date: February 16, 2024By:/s/ CECIL D. HANEY
Cecil D. HaneyDirector
Date: February 16, 2024By:/s/ J. ROBERT KERREY
J. Robert KerreyDirector
Date: February 16, 2024By:/s/ CHRIS LYNCH
Chris LynchDirector
Date: February 16, 2024By:/s/ RICHARD MARK
Richard MarkDirector
Date: February 16, 2024By:/s/ TAMMY ROMO
Tammy RomoDirector
Date: February 16, 2024By:/s/ STEPHEN H. RUSCKOWSKI
Stephen H. RusckowskiDirector
Date: February 16, 2024By:/s/ NADJA WEST
Nadja West, M.D.Director

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(In Millions)

Balance atBeginningof PeriodCosts andExpenses(1)DeductionsOtherItemsBalance atEnd ofPeriod
Valuation allowance for deferred tax assets:
Year ended December 31, 2023$177$71$—$—$248
Year ended December 31, 2022$57$120$—$—$177
Year ended December 31, 2021$55$2$—$—$57
(1)Includes amounts recorded in discontinued operations.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.